LABCORP HOLDINGS INC (LH) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:LH • US5049221055

289.89 USD
+5.39 (+1.89%)
At close: Feb 11, 2026
291 USD
+1.11 (+0.38%)
After Hours: 2/11/2026, 8:04:00 PM
Fundamental Rating

5

Overall LH gets a fundamental rating of 5 out of 10. We evaluated LH against 102 industry peers in the Health Care Providers & Services industry. LH has only an average score on both its financial health and profitability. LH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • LH had positive earnings in the past year.
  • LH had a positive operating cash flow in the past year.
  • Each year in the past 5 years LH has been profitable.
  • In the past 5 years LH always reported a positive cash flow from operatings.
LH Yearly Net Income VS EBIT VS OCF VS FCFLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

  • LH has a Return On Assets of 4.68%. This is in the better half of the industry: LH outperforms 76.47% of its industry peers.
  • LH has a better Return On Equity (9.83%) than 70.59% of its industry peers.
  • LH has a better Return On Invested Capital (6.32%) than 64.71% of its industry peers.
  • LH had an Average Return On Invested Capital over the past 3 years of 6.31%. This is below the industry average of 9.04%.
  • The last Return On Invested Capital (6.32%) for LH is above the 3 year average (6.31%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.68%
ROE 9.83%
ROIC 6.32%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
LH Yearly ROA, ROE, ROICLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • LH has a better Profit Margin (6.21%) than 82.35% of its industry peers.
  • LH's Profit Margin has declined in the last couple of years.
  • The Operating Margin of LH (9.92%) is better than 79.41% of its industry peers.
  • In the last couple of years the Operating Margin of LH has declined.
  • With a Gross Margin value of 28.45%, LH perfoms like the industry average, outperforming 57.84% of the companies in the same industry.
  • LH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.92%
PM (TTM) 6.21%
GM 28.45%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
LH Yearly Profit, Operating, Gross MarginsLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LH is destroying value.
  • Compared to 1 year ago, LH has less shares outstanding
  • LH has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, LH has a worse debt to assets ratio.
LH Yearly Shares OutstandingLH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LH Yearly Total Debt VS Total AssetsLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 3.24 indicates that LH is not in any danger for bankruptcy at the moment.
  • LH has a Altman-Z score of 3.24. This is in the better half of the industry: LH outperforms 69.61% of its industry peers.
  • The Debt to FCF ratio of LH is 4.09, which is a neutral value as it means it would take LH, 4.09 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of LH (4.09) is better than 69.61% of its industry peers.
  • A Debt/Equity ratio of 0.59 indicates that LH is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.59, LH perfoms like the industry average, outperforming 57.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.09
Altman-Z 3.24
ROIC/WACC0.77
WACC8.23%
LH Yearly LT Debt VS Equity VS FCFLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

  • LH has a Current Ratio of 1.55. This is a normal value and indicates that LH is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.55, LH is in line with its industry, outperforming 57.84% of the companies in the same industry.
  • LH has a Quick Ratio of 1.35. This is a normal value and indicates that LH is financially healthy and should not expect problems in meeting its short term obligations.
  • LH has a Quick ratio (1.35) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.35
LH Yearly Current Assets VS Current LiabilitesLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 9.71% over the past year.
  • The Earnings Per Share has been growing slightly by 5.20% on average over the past years.
  • Looking at the last year, LH shows a quite strong growth in Revenue. The Revenue has grown by 8.28% in the last year.
  • LH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.40% yearly.
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%

3.2 Future

  • LH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.93% yearly.
  • LH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y15.42%
EPS Next 2Y11.18%
EPS Next 3Y10.49%
EPS Next 5Y7.93%
Revenue Next Year7.74%
Revenue Next 2Y6.09%
Revenue Next 3Y5.71%
Revenue Next 5Y4.05%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LH Yearly Revenue VS EstimatesLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
LH Yearly EPS VS EstimatesLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.32, the valuation of LH can be described as rather expensive.
  • 76.47% of the companies in the same industry are more expensive than LH, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of LH to the average of the S&P500 Index (28.23), we can say LH is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 16.09, which indicates a correct valuation of LH.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LH indicates a somewhat cheap valuation: LH is cheaper than 75.49% of the companies listed in the same industry.
  • LH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.01.
Industry RankSector Rank
PE 18.32
Fwd PE 16.09
LH Price Earnings VS Forward Price EarningsLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • LH's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, LH is valued a bit cheaper than 72.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.4
EV/EBITDA 15.02
LH Per share dataLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.19
PEG (5Y)3.53
EPS Next 2Y11.18%
EPS Next 3Y10.49%

5

5. Dividend

5.1 Amount

  • LH has a Yearly Dividend Yield of 1.04%. Purely for dividend investing, there may be better candidates out there.
  • LH's Dividend Yield is rather good when compared to the industry average which is at 0.47. LH pays more dividend than 86.27% of the companies in the same industry.
  • With a Dividend Yield of 1.04, LH pays less dividend than the S&P500 average, which is at 1.79.
Industry RankSector Rank
Dividend Yield 1.04%

5.2 History

  • On average, the dividend of LH grows each year by 96.38%, which is quite nice.
  • LH has been paying a dividend for over 5 years, so it has already some track record.
  • LH has decreased its dividend in the last 3 years.
Dividend Growth(5Y)96.38%
Div Incr Years2
Div Non Decr Years2
LH Yearly Dividends per shareLH Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • LH pays out 28.24% of its income as dividend. This is a sustainable payout ratio.
  • LH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.24%
EPS Next 2Y11.18%
EPS Next 3Y10.49%
LH Yearly Income VS Free CF VS DividendLH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
LH Dividend Payout.LH Dividend Payout, showing the Payout Ratio.LH Dividend Payout.PayoutRetained Earnings

LABCORP HOLDINGS INC

NYSE:LH (2/11/2026, 8:04:00 PM)

After market: 291 +1.11 (+0.38%)

289.89

+5.39 (+1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28
Earnings (Next)02-17
Inst Owners98.13%
Inst Owner Change-1.99%
Ins Owners0.31%
Ins Owner Change-1.31%
Market Cap24.03B
Revenue(TTM)13.77B
Net Income(TTM)855.20M
Analysts82.76
Price Target306.09 (5.59%)
Short Float %3.67%
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield 1.04%
Yearly Dividend2.91
Dividend Growth(5Y)96.38%
DP28.24%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.25%
Min EPS beat(2)-1.84%
Max EPS beat(2)1.34%
EPS beat(4)1
Avg EPS beat(4)-0.49%
Min EPS beat(4)-1.84%
Max EPS beat(4)1.34%
EPS beat(8)3
Avg EPS beat(8)-0.27%
EPS beat(12)4
Avg EPS beat(12)-0.63%
EPS beat(16)6
Avg EPS beat(16)0.3%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-2.8%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-2.81%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-2.35%
Revenue beat(12)0
Avg Revenue beat(12)-5.86%
Revenue beat(16)0
Avg Revenue beat(16)-13.64%
PT rev (1m)0.11%
PT rev (3m)-0.31%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)-0.76%
EPS NY rev (1m)0.01%
EPS NY rev (3m)0.07%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE 18.32
Fwd PE 16.09
P/S 1.75
P/FCF 17.4
P/OCF 13.33
P/B 2.76
P/tB N/A
EV/EBITDA 15.02
EPS(TTM)15.82
EY5.46%
EPS(NY)18.01
Fwd EY6.21%
FCF(TTM)16.66
FCFY5.75%
OCF(TTM)21.76
OCFY7.5%
SpS166.05
BVpS104.91
TBVpS-18.78
PEG (NY)1.19
PEG (5Y)3.53
Graham Number193.24
Profitability
Industry RankSector Rank
ROA 4.68%
ROE 9.83%
ROCE 8.73%
ROIC 6.32%
ROICexc 6.57%
ROICexgc 20.66%
OM 9.92%
PM (TTM) 6.21%
GM 28.45%
FCFM 10.03%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
ROICexc(3y)6.66%
ROICexc(5y)9.53%
ROICexgc(3y)24.5%
ROICexgc(5y)35.7%
ROCE(3y)8.72%
ROCE(5y)12.25%
ROICexgc growth 3Y-23.52%
ROICexgc growth 5Y-8.03%
ROICexc growth 3Y-23.85%
ROICexc growth 5Y-3.15%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
F-Score9
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.09
Debt/EBITDA 2.7
Cap/Depr 77.99%
Cap/Sales 3.07%
Interest Coverage 5.52
Cash Conversion 94.58%
Profit Quality 161.46%
Current Ratio 1.55
Quick Ratio 1.35
Altman-Z 3.24
F-Score9
WACC8.23%
ROIC/WACC0.77
Cap/Depr(3y)76.91%
Cap/Depr(5y)70.72%
Cap/Sales(3y)3.85%
Cap/Sales(5y)3.56%
Profit Quality(3y)157.09%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
EPS Next Y15.42%
EPS Next 2Y11.18%
EPS Next 3Y10.49%
EPS Next 5Y7.93%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%
Revenue Next Year7.74%
Revenue Next 2Y6.09%
Revenue Next 3Y5.71%
Revenue Next 5Y4.05%
EBIT growth 1Y20.09%
EBIT growth 3Y-28.19%
EBIT growth 5Y-5.19%
EBIT Next Year33.83%
EBIT Next 3Y14.37%
EBIT Next 5Y12.85%
FCF growth 1Y38.44%
FCF growth 3Y-25.49%
FCF growth 5Y0.97%
OCF growth 1Y28.67%
OCF growth 3Y-20.11%
OCF growth 5Y1.88%

LABCORP HOLDINGS INC / LH FAQ

What is the ChartMill fundamental rating of LABCORP HOLDINGS INC (LH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to LH.


What is the valuation status for LH stock?

ChartMill assigns a valuation rating of 5 / 10 to LABCORP HOLDINGS INC (LH). This can be considered as Fairly Valued.


What is the profitability of LH stock?

LABCORP HOLDINGS INC (LH) has a profitability rating of 6 / 10.


What is the valuation of LABCORP HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LABCORP HOLDINGS INC (LH) is 18.32 and the Price/Book (PB) ratio is 2.76.


What is the expected EPS growth for LABCORP HOLDINGS INC (LH) stock?

The Earnings per Share (EPS) of LABCORP HOLDINGS INC (LH) is expected to grow by 15.42% in the next year.